Intestinal calcium absorption during hyperinsulinemic euglycemic glucose clamp in healthy humans - PubMed (original) (raw)

Intestinal calcium absorption during hyperinsulinemic euglycemic glucose clamp in healthy humans

G Rümenapf et al. Calcif Tissue Int. 1990 Feb.

Abstract

The influence of postprandial-like plasma insulin levels on intestinal calcium absorption (CaA) was studied in 9 healthy men. On separate occasions, they received either an i.v. infusion of 40 mU/m2 minute synthetic human insulin as well as a variable glucose infusion in order to clamp the plasma glucose at the baseline level (= glucose clamp), or insulin- and glucose-free vehicle infusions (= vehicle). During these infusions, an oral load containing 326 mg Ca in the form of Ca chloride was administered and CaA was determined thereafter with a 47Ca/85Sr double tracer method. During glucose clamp, mean plasma insulin was 172 +/- (1 SEM) 10 as compared to 6 +/- 1 microU/ml during vehicle infusions. During the clamp, 3-hour cumulative CaA rose significantly by 14% as compared to vehicle (39.2 +/- 2.5 vs. 34.4 +/- 2%, P less than 0.02). AT the same time, serum potassium and phosphorus dropped significantly, whereas serum parathyroid hormone (PTH) and 1,25(OH)2D levels were unchanged as compared to vehicle. The urinary excretions of potassium, sodium, and inorganic phosphorus, as well as the urinary specific activity of 47Ca, dropped significantly during glucose clamp, whereas the urinary excretion of cAMP was unchanged as compared to vehicle. The results suggest that, under the conditions of euglycemic hyperinsulinemic clamp, insulin stimulates CaA of healthy humans in a PTH- and 1,25(OH)2D-independent manner. Insulin may thus possibly be regarded as a factor participating in the regulation of CaA in humans.

PubMed Disclaimer

Similar articles

• Effects of hyperinsulinemia under the euglycemic condition on calcium and phosphate metabolism in non-obese normotensive subjects.
  Shimamoto K, Higashiura K, Nakagawa M, Masuda A, Shiiki M, Miyazaki Y, Ise T, Fukuoka M, Hirata A, Iimura O. Shimamoto K, et al. Tohoku J Exp Med. 1995 Dec;177(4):271-8. doi: 10.1620/tjem.177.271. Tohoku J Exp Med. 1995. PMID: 8928187 Clinical Trial.
• The influence of progressive hyperinsulinemia on duodenal calcium absorption in the rat.
  Rümenapf G, Issa S, Schwille PO. Rümenapf G, et al. Metabolism. 1987 Jan;36(1):60-5. doi: 10.1016/0026-0495(87)90064-3. Metabolism. 1987. PMID: 2879209
• The influence of oral alkali citrate on intestinal calcium absorption in healthy man.
  Rümenapf G, Schwille PO. Rümenapf G, et al. Clin Sci (Lond). 1987 Jul;73(1):117-21. doi: 10.1042/cs0730117. Clin Sci (Lond). 1987. PMID: 3608372 Clinical Trial.
• Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions.
  Nowicki M, Fliser D, Fode P, Ritz E. Nowicki M, et al. J Clin Endocrinol Metab. 1996 Jan;81(1):156-9. doi: 10.1210/jcem.81.1.8550745. J Clin Endocrinol Metab. 1996. PMID: 8550745 Clinical Trial.
• The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism.
  Breslau NA, McGuire JL, Zerwekh JE, Pak CY. Breslau NA, et al. J Clin Endocrinol Metab. 1982 Aug;55(2):369-73. doi: 10.1210/jcem-55-2-369. J Clin Endocrinol Metab. 1982. PMID: 6896338

Cited by

• Environmental factors in the pathophysiology of recurrent idiopathic calcium urolithiasis (RCU), with emphasis on nutrition.
  Schwille PO, Herrmann U. Schwille PO, et al. Urol Res. 1992;20(1):72-83. doi: 10.1007/BF00294342. Urol Res. 1992. PMID: 1736491 Review.
• A prospective evaluation of obesometric parameters associated with renal stone recurrence.
  Bos D, Dason S, Matsumoto E, Pinthus J, Allard C. Bos D, et al. Can Urol Assoc J. 2016 Aug;10(7-8):234-238. doi: 10.5489/cuaj.3876. Can Urol Assoc J. 2016. PMID: 27878041 Free PMC article.
• Prevalence of kidney stones in the United States.
  Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Scales CD Jr, et al. Eur Urol. 2012 Jul;62(1):160-5. doi: 10.1016/j.eururo.2012.03.052. Epub 2012 Mar 31. Eur Urol. 2012. PMID: 22498635 Free PMC article.
• The Changing Incidence and Presentation of Urinary Stones Over 3 Decades.
  Kittanamongkolchai W, Vaughan LE, Enders FT, Dhondup T, Mehta RA, Krambeck AE, McCollough CH, Vrtiska TJ, Lieske JC, Rule AD. Kittanamongkolchai W, et al. Mayo Clin Proc. 2018 Mar;93(3):291-299. doi: 10.1016/j.mayocp.2017.11.018. Epub 2018 Feb 14. Mayo Clin Proc. 2018. PMID: 29452705 Free PMC article.

References

1. 1. Am J Physiol. 1980 Mar;238(3):E200-7 - PubMed
2. 1. Br J Urol. 1982 Dec;54(6):575-7 - PubMed
3. 1. Adv Cyclic Nucleotide Res. 1972;2:25-40 - PubMed
4. 1. J Clin Endocrinol Metab. 1965 Oct;25(10 ):1375-84 - PubMed
5. 1. Diabetes. 1977 Nov;26(11):1052-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Research Materials

  • NCI CPTC Antibody Characterization Program